CLINICAL TRIALS PROFILE FOR CORTROSYN
✉ Email this page to a colleague
All Clinical Trials for CORTROSYN
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00462644 ↗ | Evaluation of Etomidate on Adrenal Function in Trauma Patients | Completed | University of Tennessee | N/A | 2006-02-01 | Trauma patients are at increased risk for adrenal function insufficiency. A commonly used agent for rapid sequence intubation (RSI) is known to decrease adrenal function. We want to determine the incidence of adrenocortical insufficiency and its significance during the first 24 hours of resuscitation following RSI in trauma patients. |
NCT00484679 ↗ | Adrenal Function and Use of Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10) in Patients With Alopecia Areata | Completed | National Alopecia Areata Foundation | Phase 2 | 2007-05-01 | The purpose of the study is to see whether treating alopecia areata with injections of the corticosteroid, Triamcinolone acetonide 10mg/cc (Kenalog-10), has an impact on the adrenal glands. |
NCT00484679 ↗ | Adrenal Function and Use of Intralesional Triamcinolone Acetonide 10 mg/mL (Kenalog-10) in Patients With Alopecia Areata | Completed | University of Minnesota | Phase 2 | 2007-05-01 | The purpose of the study is to see whether treating alopecia areata with injections of the corticosteroid, Triamcinolone acetonide 10mg/cc (Kenalog-10), has an impact on the adrenal glands. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for CORTROSYN
Condition Name
Clinical Trial Locations for CORTROSYN
Trials by Country
Clinical Trial Progress for CORTROSYN
Clinical Trial Phase
Clinical Trial Sponsors for CORTROSYN
Sponsor Name